Evidence map›Paper›PMID 38935428›Full record

ArticleJMIR formative research2024

Clinicians' Perspectives on the Telehealth Serious Illness Care Program for Older Adults With Myeloid Malignancies: Single-Arm Pilot Study.

Marissa LoCastro, Ying Wang, Tristan Yu, Soroush Mortaz-Hedjri, Jason Mendler, Sally Norton, Rachelle Bernacki, Thomas Carroll, Heidi Klepin, Lucy Wedow and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04745676 (A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04745676 nacompletednot on this map

A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

TypeinterventionalSponsorUniversity of RochesterRan2021 to 2023Enrolled36ConditionsAcute Myeloid Leukemia, Myelodysplastic SyndromesArmsTelehealth, Control
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marissa LoCastroSchool of Medicine and Dentistry, University of Rochester, Rochester, NY, United States.ORCID https://orcid.org/0000-0002-1075-8443
Ying WangDepartment of Epidemiology, University of Rochester Medical Center, Rochester, NY, United States.ORCID https://orcid.org/0000-0002-2317-8915
Tristan YuRiver Campus, University of Rochester, Rochester, NY, United States.ORCID https://orcid.org/0009-0003-0441-5756
Soroush Mortaz-HedjriDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0009-0007-4135-3119
Jason MendlerDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0000-0001-5605-5324
Sally NortonSchool of Nursing, University of Rochester Medical Center, Rochester, NY, United States.ORCID https://orcid.org/0000-0001-7686-6327
Rachelle BernackiDepartment of Palliative Care, Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0003-0873-7931
Thomas CarrollDivisions of General Medicine and Palliative Care, University of Rochester Medical Center, Rochester, NY, United States.ORCID https://orcid.org/0000-0003-4887-9651
Heidi KlepinSection on Hematology and Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-6262-1123
Lucy WedowDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0009-0005-9078-4471
Sean GoonanDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0009-0001-7151-6894
Hannah ErdosDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0009-0003-3913-4495
Brenda BagnatoDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0009-0004-1225-1314
Jane LiesveldDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0000-0002-3386-8469
Eric HuseltonDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0000-0003-3397-7435
Benzi KlugerDivisions of Palliative Care and Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States.ORCID https://orcid.org/0000-0002-6259-329X
Kah Poh LohDivision of Hematology Oncology, Department of Medicine, James P. Wilmot Cancer Institute, Rochester, NY, United States.ORCID https://orcid.org/0000-0002-6978-0418

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
NRSA Training CoreTL1TR002000 · NCATS · UNIVERSITY OF ROCHESTER · PI THAKAR, JUILEE, VAN WIJNGAARDEN, EDWIN · 2016 to 2024
$4.1M
A novel mobile health exercise intervention for older patients with myeloid neoplasmsR00CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2021 to 2023
$747k
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related DementiasK02AG062745 · NIA · UNIVERSITY OF ROCHESTER · PI KLUGER, BENZI M · 2020 to 2024
$711k
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
Epigenetic markers, functional status, and exercise in older adults with myeloid neoplasmsR03AG073985 · NIA · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2022 to 2023
$308k
NCATS NIH HHS TL1 TR002000NCI NIH HHS K99 CA237744NCI NIH HHS R00 CA237744NCI NIH HHS UG1 CA189961NIA NIH HHS K02 AG062745NIA NIH HHS R03 AG073985NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

backgroundSerious illness conversations may help patients avoid unwanted treatments. We previously piloted the telehealth Serious Illness Care Program (SICP) for older adults with acute myeloid leukemia and myelodysplastic syndrome.

objectiveIn this study, we aimed to understand the experience of the telehealth SICP from the clinician's perspective.

methodsWe studied 10 clinicians who delivered the telehealth SICP to 20 older adults with acute myeloid leukemia or myelodysplastic syndrome. Quantitative outcomes included confidence and acceptability. Confidence was measured using a 22-item survey (range 1-7; a higher score is better). Acceptability was measured using an 11-item survey (5-point Likert scale). Hypothesis testing was performed at α=.10 (2-tailed) due to the pilot nature and small sample size. Clinicians participated in audio-recorded qualitative interviews at the end of the study to discuss their experience.

resultsA total of 8 clinicians completed the confidence measure and 7 clinicians completed the acceptability measure. We found a statistically significant increase in overall confidence (mean increase of 0.5, SD 0.6; P=.03). The largest increase in confidence was in helping families with reconciliation and goodbye (mean 1.4, SD 1.5; P=.04). The majority of clinicians agreed that the format was simple (6/7, 86%) and easy to use (6/7, 86%). Clinicians felt that the telehealth SICP was effective in understanding their patients' values about end-of-life care (7/7, 100%). A total of three qualitative themes emerged: (1) the telehealth SICP deepened relationships and renewed trust; (2) each telehealth SICP visit felt unique and personal in a positive way; and (3) uninterrupted, unrushed time optimized the visit experience.

conclusionsThe telehealth SICP increased confidence in having serious illness conversations while deepening patient-clinician relationships.

trial registrationClinicalTrials.gov NCT04745676; https://www.clinicaltrials.gov/study/NCT04745676.

Indexed as

acute myeloid leukemiaAMLcancergeriatric oncologyhematologic malignancyMDSmetastasesmyelodysplastic syndromeoncologistoncologistsoncologySerious Illness Care Programserious illness conversationserious illness conversationsSICSICPtele-healthtelehealthtele-medicinetelemedicine

Identifiers

PMID38935428
PMCPMC11240066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.